Elevance Health Inc (NYSE: ELV) and Cigna Group's (NYSE: CI) Express Scripts have finally ended their prolonged legal battle by settling the last unresolved claim in a contentious contract dispute, paving th
Eli Lilly And Co's (NYSE: LLY) investigational RNA-directed drug lepodisiran lowered lipoprotein(a) levels in a Phase 1 study. Elevated levels of Lp(a) have been associated with a higher risk of heart disease, heart attack, and stroke.
Selecta Biosciences Inc (NASDAQ: SELB) and Cartesian Therapeutics Inc announced a reverse merger in an all-stock deal, with Selecta shareholders owning